(19)
(11) EP 3 694 519 A2

(12)

(88) Date of publication A3:
31.05.2019

(43) Date of publication:
19.08.2020 Bulletin 2020/34

(21) Application number: 18865578.1

(22) Date of filing: 08.10.2018
(51) International Patent Classification (IPC): 
A61K 31/4985(2006.01)
A61K 9/48(2006.01)
A61K 9/54(2006.01)
A61K 9/50(2006.01)
A61K 31/138(2006.01)
A61K 9/52(2006.01)
A61K 9/16(2006.01)
(86) International application number:
PCT/TR2018/050568
(87) International publication number:
WO 2019/074464 (18.04.2019 Gazette 2019/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.10.2017 TR 201715231

(71) Applicant: Montero Gida Sanayi Ve Ticaret Anonim Sirketi
34460 Istanbul (TR)

(72) Inventors:
  • TÜRKYILMAZ, Ali
    34460 Istanbul (TR)
  • PALANTÖKEN, Arzu
    34398 Istanbul (TR)
  • GÜNER, Dicle
    34460 Istanbul (TR)

(74) Representative: Mutlu, Aydin 
Invokat Intellectual Property Services Ltd. Kartaltepe Mh. Yildiztepe Sk. No:6-Bakirköy
34145 Istanbul
34145 Istanbul (TR)

   


(54) THE PHARMACEUTICAL COMBINATION COMPRISING DAPOXETINE AND PHOSPHODIESTERASE TYPE-5